Strides Pharma Science Limited engages in the development, manufacturing, and global distribution of pharmaceutical products across Africa, Australia, North America, Europe, Asia, and India. The company operates through two main segments: Pharmaceutical and Biopharmaceutical. Its product portfolio includes pharmaceutical generics in various forms such as tablets, capsules, sachets, liquids, nasal spray, powders, ointments, and creams. Additionally, the company specializes in the creation of branded generics addressing chronic therapies like women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics, marketed under brands like Renerve, Unibrol, Combiart, Duotab, and Vitafer. Strides Pharma Science Limited also caters to institutional business with anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments. Formerly known as Strides Shasun Limited, the company changed its name to Strides Pharma Science Limited in July 2018. Established in 1990, its headquarters are located in Bengaluru, India.
Navigation section
Strides Pharma Science Limited
- 716.65 34.10(5.00%) 748.45 35.60(4.99%)
Performance
| Today's Low | Today's High | |
|---|---|---|
| 716.65 735.00 | 716.65 748.45 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 482.00 (07-Dec-2023) 233.38 (08-Dec-2023) | 1,675.00 (17-Oct-2024) 804.12 (17-Oct-2024) |
- Open
- 716.65 744.00
- Previous Close
- 682.55 712.85
- Volume
- 0.05
- Total Traded value
- 0.38 (₹ Lakhs)
- Upper circuit
- 716.65 826.20
- Lower circuit
- 648.45 550.80
Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 108,078 | 0 |
| Bid Price | Quantity |
|---|---|
| 716.65 | 108,078.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | 108,078 |
| Ask Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
Fundamentals
| Market Cap: | ₹66.05 Cr |
| PE Ratio (TTM): | 86.90 |
| PB Ratio: | 1.86 |
| Industry P/E: | 19.67 |
| Debt to Equity: | - |
| ROE: | 2.14 |
| EPS (TTM): | 8.20 |
| Book Value: | 3.59 |
| Face Value: | 10.00 |
Financials
| Sep, 2022 | Sep, 2023 | Sep, 2022 | Sep, 2022 | Mar, 2023 | |
|---|---|---|---|---|---|
| Revenue | 10.27 Cr | 2.74 Cr | 323.55 Cr | 119.18 Cr | 563.56 Cr |
| Profit | -0.10 Cr | -5.51 Cr | 16.94 Cr | 36.26 Cr | 62.40 Cr |
| Expense | 10.69 Cr | 9.13 Cr | 307.62 Cr | 78.87 Cr | 509.74 Cr |
| Comprehensive income | -0.10 Cr | -5.49 Cr | 92.24 Cr | 35.83 Cr | 77.02 Cr |
| EPS | -0.01 | -0.79 | 29.99 | 9.62 | 6.91 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| Strides Pharma Science Limited | Mar, 2000 Jun, 2004 | Pharmaceuticals Pharmaceuticals | STAR STAR |
Shareholding pattern
Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022
Strides Pharma Science Limited FAQ's
What is the range of today's stock performance for Strides Pharma Science Limited?
Today's stock performance witnessed a fluctuation from a minimum of 716.65 on the NSE (National Stock Exchange) to a maximum of 716.65. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 735.00 to a high of 748.45.
What are the 52-week low and high values for Strides Pharma Science Limited?
The stock's performance over the past 52 weeks reveals a low of 482.00 (occurred on 07-Dec-2023) and a high of 1,675.00 (achieved on 17-Oct-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 233.38 (on 08-Dec-2023), and the 52-week high is 804.12 (on 17-Oct-2024).
What was the opening and previous closing prices for Strides Pharma Science Limited?
The stock's performance over the past 52 weeks reveals a low of 482.00 (occurred on 07-Dec-2023) and a high of 1,675.00 (achieved on 17-Oct-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 233.38 (on 08-Dec-2023), and the 52-week high is 804.12 (on 17-Oct-2024).
What is the total volume and traded value for Strides Pharma Science Limited for the day?
The total volume is 0, and the total traded value is 0.38 (₹ Lakhs).
What are the upper and lower circuit limits for Strides Pharma Science Limited?
The upper circuit limit is 716.65, and the lower circuit limit is 648.45.
What is the market cap and PE ratio for Strides Pharma Science Limited?
The market cap is ₹66.05 Cr, and the PE ratio (TTM) is 21.15.
What is the PB ratio, industry P/E, and debt to equity ratio for Strides Pharma Science Limited?
The PB ratio is 199.79, industry P/E is 19.67 .
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Strides Pharma Science Limited?
ROE is 2.14, EPS is 8.20, book value is 3.59
What are the revenue and profit figures for the latest quarter and previous quarters for Strides Pharma Science Limited?
In Sep 2022, Revenue is ₹102708000, and Profit is ₹-988000. In Sep 2023, Revenue is ₹27362000.00, and Profit is ₹-55117000.00.
When was Strides Pharma Science Limited listed, and what industry does it belong to?
The company, Strides Pharma Science Limited, was listed in Mar 2000 and belongs to the Pharmaceuticals industry. Its NSE symbol is STAR.
What is the current shareholding pattern of the Strides Pharma Science Limited?
As of latest available update, promoters hold 27.78%, the public holds 72.22%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 29
- Threads
- 94
